Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
technetium-99m + diethylenetriaminepentaacetic acid (Cliniques universitaires Saint-Luc)
- Development stage
- Unknown
- Lead developer
- PDRadiopharma
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Inhalation
01
Overview
Technetium-99m diethylenetriaminepentaacetic acid (99mTc-DTPA) is a radioactive diagnostic tracer used for medical imaging, particularly in evaluating lung ventilation and aerosol distribution. It consists of the gamma-emitting radioisotope technetium-99m chelated by diethylenetriaminepentaacetic acid (pentetic acid). In the clinical research context at Cliniques universitaires Saint-Luc, the tracer is administered as a nebulized aerosol to healthy volunteers to compare the efficiency and distribution patterns of different nebulizer systems (vibrating-mesh vs. jet nebulizers) using Single Photon Emission Computed Tomography (SPECT-CT). The complex is highly stable and, when inhaled, allows for the visualization of regional lung ventilation and the assessment of alveolar-capillary membrane permeability.
- Other names
- technetium-99m pentetatetechnetium99m pentetatetechnetium 99m pentetate99mTc-pentetic acidtechnetium-99m diethylenetriaminepentaacetic acidtechnetium99m diethylenetriaminepentaacetic acidtechnetium 99m diethylenetriaminepentaacetic acid
Beyond the preview
Go deeper on technetium-99m + diethylenetriaminepentaacetic acid (Cliniques universitaires Saint-Luc).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on technetium-99m + diethylenetriaminepentaacetic acid (Cliniques universitaires Saint-Luc).